Basics Black Diamond Therapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $134.76M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.71% Avg Daily Range (30 D): $0.07 | 3.56% Avg Daily Range (90 D): $0.08 | 4.04% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): 1.07M Avg Daily Volume (90 D): 2.26M Trade Size Avg Trade Size (Sh.): 141 Avg Trade Size (Sh.) (30 D): 200 Avg Trade Size (Sh.) (90 D): 247 Institutional Trades Total Inst.Trades: 367 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.51M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.24M Avg Closing Trade (30 D): $.51M Avg Closing Trade (90 D): $.51M Avg Closing Volume: 152.8K     News Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Nov 5, 2024 @ 1:00 PM Black Diamond Therapeutics Reports Third Quarter 2... Source: N/A Oct 7, 2024 @ 8:01 PM Black Diamond Therapeutics Announces Restructuring... Source: N/A Sep 22, 2024 @ 2:00 PM Black Diamond Therapeutics to Host Webcast Present... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $1 $-.28 $-1.27 Diluted EPS $.98 $-.28 $-1.27 Revenue $ 70M $ M $ M Gross Profit $ $ $ Net Income / Loss $ 56.54M $ -15.99M $ -69.68M Operating Income / Loss $ 54.53M $ -18.28M $ -78.78M Cost of Revenue $ $ $ Net Cash Flow $ 61.99M $ 13.01M $ -19.79M PE Ratio 2.64